Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease

5th April 2017 Uncategorised 0

Teva Pharmaceutical Industries

More: Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease
Source: MDlinx